188 related articles for article (PubMed ID: 10954581)
1. The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages.
Alfano M; Pushkarsky T; Poli G; Bukrinsky M
J Virol; 2000 Sep; 74(18):8767-70. PubMed ID: 10954581
[TBL] [Abstract][Full Text] [Related]
2. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains.
Alfano M; Schmidtmayerova H; Amella CA; Pushkarsky T; Bukrinsky M
J Exp Med; 1999 Sep; 190(5):597-605. PubMed ID: 10477545
[TBL] [Abstract][Full Text] [Related]
3. The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cells.
Alfano M; Vallanti G; Biswas P; Bovolenta C; Vicenzi E; Mantelli B; Pushkarsky T; Rappuoli R; Lazzarin A; Bukrinsky M; Poli G
J Immunol; 2001 Feb; 166(3):1863-70. PubMed ID: 11160233
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of intra- and extra-cellular Tat function and HIV expression by pertussis toxin B-oligomer.
Rizzi C; Alfano M; Bugatti A; Camozzi M; Poli G; Rusnati M
Eur J Immunol; 2004 Feb; 34(2):530-6. PubMed ID: 14768058
[TBL] [Abstract][Full Text] [Related]
5. Pertussis toxin enhances human immunodeficiency virus type 1 replication.
Momoi Y; Ichiyama K; Chowdhury IH; Koyanagi Y; Yamamoto N
AIDS Res Hum Retroviruses; 2000 Mar; 16(4):373-9. PubMed ID: 10716375
[TBL] [Abstract][Full Text] [Related]
6. Pertussis toxin B-oligomer suppresses IL-6 induced HIV-1 and chemokine expression in chronically infected U1 cells via inhibition of activator protein 1.
Rizzi C; Crippa MP; Jeeninga RE; Berkhout B; Blasi F; Poli G; Alfano M
J Immunol; 2006 Jan; 176(2):999-1006. PubMed ID: 16393986
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.
Takashima K; Miyake H; Furuta RA; Fujisawa JI; Iizawa Y; Kanzaki N; Shiraishi M; Okonogi K; Baba M
Antimicrob Agents Chemother; 2001 Dec; 45(12):3538-43. PubMed ID: 11709336
[TBL] [Abstract][Full Text] [Related]
8. B-oligomer of pertussis toxin inhibits HIV-1 LTR-driven transcription through suppression of NF-kappaB p65 subunit activity.
Iordanskiy S; Iordanskaya T; Quivy V; Van Lint C; Bukrinsky M
Virology; 2002 Oct; 302(1):195-206. PubMed ID: 12429528
[TBL] [Abstract][Full Text] [Related]
9. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
Chang LJ; Zhang C
Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
[TBL] [Abstract][Full Text] [Related]
12. Highly productive infection with pseudotyped human immunodeficiency virus type 1 (HIV-1) indicates no intracellular restrictions to HIV-1 replication in primary human astrocytes.
Canki M; Thai JN; Chao W; Ghorpade A; Potash MJ; Volsky DJ
J Virol; 2001 Sep; 75(17):7925-33. PubMed ID: 11483737
[TBL] [Abstract][Full Text] [Related]
13. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
Chen H; He J; Fong S; Wilcox G; Wood C
J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.
Su Y; Popik W; Pitha PM
J Virol; 1995 Jan; 69(1):110-21. PubMed ID: 7983701
[TBL] [Abstract][Full Text] [Related]
15. The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication.
Roy J; Paquette JS; Fortin JF; Tremblay MJ
Antimicrob Agents Chemother; 2002 Nov; 46(11):3447-55. PubMed ID: 12384349
[TBL] [Abstract][Full Text] [Related]
16. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
Lapenta C; Spada M; Santini SM; Racca S; Dorigatti F; Poli G; Belardelli F; Alfano M
Int Immunol; 2005 Apr; 17(4):469-75. PubMed ID: 15746245
[TBL] [Abstract][Full Text] [Related]
17. Pertussis toxin B-oligomer dissociates T cell activation and HIV replication in CD4 T cells released from infected lymphoid tissue.
Alfano M; Grivel JC; Ghezzi S; Corti D; Trimarchi M; Poli G; Margolis L
AIDS; 2005 Jul; 19(10):1007-14. PubMed ID: 15958831
[TBL] [Abstract][Full Text] [Related]
18. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
[TBL] [Abstract][Full Text] [Related]
19. H. saimiri tyrosine-kinase interacting protein inhibits Tat function: a prototypic strategy for restricting HIV-1-induced cytopathic effects in immune cells.
Raymond AD; Hasham M; Tsygankov AY; Henderson EE
Virology; 2006 Sep; 352(2):253-67. PubMed ID: 16780912
[TBL] [Abstract][Full Text] [Related]
20. Herpesvirus saimiri terminal membrane proteins modulate HIV-1 replication by altering Nef and Tat functions.
Raymond AD; Hasham M; Tsygankov AY; Henderson EE
Curr HIV Res; 2007 Jan; 5(1):79-86. PubMed ID: 17266559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
